Home News & Events Events Events Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any - Industry Webinars Workshop Webinars Meeting Sites Where They Are: A Connected, Intelligence-Powered Operating Model Date 28 July 2026 Time 10:00 - 11:00 Location Webinar Timezone EST - America/New York Workshop NONMEM Introduction Workshop (China Region): Applications in PK/PD Modeling (Mandarin Language) Date 31 July 2026 Time 09:00 - 12:00 Location Online/Virtual Webex Timezone Asia/Shanghai Workshop NONMEM Introduction Workshop (China Region): Applications in PK/PD Modeling (Mandarin Language) Date 3 September 2026 Time 09:00 - 12:00 Location Online/Virtual Webex Timezone Asia/Shanghai Industry SCDM 2026 Annul Conference Date 14 September 2026 - 17 September 2026 Time 08:00 - 18:00 Location Raleigh, NC, USA Timezone EDT - America/New York ICON will exhibit | Booth #308 Industry OCT Southern California Date 15 September 2026 - 16 September 2026 Time 08:00 - 18:00 Location San Diego, CA, USA Timezone PDT - America/Los Angeles ICON will exhibit and speak | Booth#26 Workshop Beginners/Intermediate Online NONMEM/PDx-Pop Workshop Date 22 September 2026 - 23 September 2026 Time 09:00 - 17:00 Location Online/Virtual Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop Workshop Date 24 September 2026 Time 09:00 - 17:00 Location Online/Virtual Webex Timezone America/New York Industry World Clinical Biomarkers & CDx Summit Date 5 October 2026 - 8 October 2026 Time 08:00 - 18:00 Location Boston, MA, USA Timezone EDT - America/New York ICON will exhibit and speak Industry CPHI Milan Date 6 October 2026 - 8 October 2026 Time 08:00 - 18:00 Location Milan, Italy Timezone Europe/Rome ICON will exhibit | Booth# 8F70 1 2 3 Next In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 ISPOR EU 2026 Webinars Workshops Webinars Social media hub Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What's happening in ICON ICON Plc Italy's pharmaceutical traceability system is undergoing one of its most significant transformations in decades. New legislation will introduce a hybrid serialisation model that aligns Italy more closely with EU Falsifi... 24 Jul View post View webpage ICON Plc Earlier this month, colleagues from ICON Mexico came together for our fifth consecutive Blood Donation Campaign. Around 90 colleagues registered to take part, with 37 successfully donating blood following assessment by ... 21 Jul View post ICON Plc The EU’s PPWR is not a standalone regulatory change. It is a strategic transformation that touches the entire product lifecycle. In this article ICON’s Global Labelling & Ad Promotion team outlines practical recommendat... 21 Jul View post View webpage ICON Plc Japan is emerging as a leading destination for regenerative medicine, backed by established regulatory pathways, a large patient population, and one of the world's most comprehensive healthcare data systems. Read our lat... 21 Jul View post View webpage ICON Plc Is your COPD development programme ready for the precision medicine era? From eosinophil-driven patient selection to adaptive trial designs and the integration of real-world evidence, success increasingly depends on pre... 21 Jul View post View webpage ICON Plc Heart failure affects millions of people worldwide and can significantly impact quality of life. Research into new treatment approaches remains critical to improving outcomes and expanding options for patients living wit... 20 Jul View post View webpage ICON Plc Biomarker-based surrogate endpoints can accelerate development timelines – but only when the evidence, pathway and expectations are aligned. In the latest issue of Drug & Device World ICON’s Elizabeth Madichie and Jack ... 20 Jul View post View webpage ICON Plc "Plan early" remains key in the new EU HTA landscape. Companies should proactively map evidence needs across key countries, pursue joint scientific advice where possible, and allocate additional time and budget for anal... 17 Jul View post View webpage ICON Plc For APAC biotechs with global ambitions, choosing the right regulatory pathway can be a critical strategic decision. In PharmaTimes Magazine, ICON’s Senior Director of Regulatory Strategy, Graham Bell, explores the comp... 16 Jul View post View webpage ICON Plc Sites are often asked to adapt to sponsor and CRO processes that sit outside their day-to-day workflows. What if we took a different approach? Join Brian Mallon (ICON), Scott Uebele (Advarra), Denise Snyder (Duke Univer... 14 Jul View post View webpage ICON Plc The first EU Joint Clinical Assessments (JCAs) may reduce some duplication in clinical assessments, but they are also creating new challenges for evidence planning. Mia Malmenäs of ICON notes that manufacturers are navi... 14 Jul View post View webpage ICON Plc Companies that have not historically developed biosimilars are recognising the opportunity represented by recent regulatory changes. Discover how the biosimilars market is being impacted and how developers can help the... 14 Jul View post View webpage
